ERSPC Prostate Cancer Risk Estimator
Use this calculator to estimate the probability of prostate cancer and high-grade prostate cancer based on common ERSPC-style inputs.
What is the ERSPC risk calculator?
The ERSPC (European Randomized Study of Screening for Prostate Cancer) risk calculator is designed to estimate a man's probability of having prostate cancer, and in some versions, the probability of having clinically significant (high-grade) disease. It combines multiple variables rather than relying on PSA alone.
Why risk calculators matter
PSA values can be useful, but they are not specific for cancer. Benign enlargement, inflammation, and other non-cancer causes can raise PSA. A structured risk model can improve decision-making by putting PSA in context with age, exam findings, and prior history.
- Helps reduce unnecessary biopsies in lower-risk patients.
- Identifies men who may benefit from MRI or biopsy sooner.
- Supports shared decision-making between patient and clinician.
Inputs used in this calculator
Age
Risk generally increases with age, so age is an important baseline factor in nearly all prostate risk models.
PSA
Higher PSA levels are associated with higher risk, but interpretation depends on context such as prostate size and exam findings.
DRE result
An abnormal digital rectal exam can increase concern for clinically important disease.
Family history
A first-degree relative with prostate cancer can increase personal risk.
Previous negative biopsy
A prior negative biopsy may reduce immediate probability, though risk can still change over time.
Prostate volume and free PSA %
Larger prostate volume can dilute PSA interpretation. A higher free PSA percentage is often associated with lower cancer probability in many clinical scenarios.
How to interpret your result
After calculating, you will see two estimates:
- Any prostate cancer risk: Probability of finding prostate cancer on biopsy.
- High-grade risk: Probability of finding potentially more aggressive cancer.
Use these values as a conversation starter. Most decisions should also include MRI findings, PSA trend over time, overall health, life expectancy, and your preferences.
Important limitations
- This page provides an educational approximation of ERSPC-style risk logic.
- It is not the official hospital calculator and not a medical device.
- No online estimate can replace physician judgment, imaging, or pathology.
Practical next steps
If your estimated risk is elevated, discuss options with a urologist. Typical pathways may include repeat PSA, multiparametric MRI, biomarker testing, or biopsy depending on your full clinical picture.